141
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Penicillium janthinellum Pneumonia in an SLE Patient: A Case Study

, , , ORCID Icon, & ORCID Icon
Pages 2745-2749 | Published online: 07 Aug 2020
 

Abstract

The risk of opportunistic fungal infections is high in immunocompromised patients. The Penicillium genus is common and diverse in nature. However, it rarely causes infection in humans. Here, we reported a case of Penicillium janthinellum pneumonia in a systemic lupus erythematosus (SLE) patient, and the morphological characteristics of P. janthinellum were also described. The patient was a 64-year-old female. She had been diagnosed with SLE and membranous lupus nephritis 10 months previously. Her medications included methylprednisolone, cyclosporine, and hydroxychloroquine. She was admitted because of fever and diagnosed with pneumonia. P. janthinellum was isolated from sputum and bronchoalveolar lavage (BAL) samples. BAL fluid stained with multiple stains showed the presence of somewhat dichotomously branching septate fungal hyphae. P. janthinellum was identified, and its morphological features were described. Antibiotic susceptibility profiles showed that this strain had higher minimum inhibitory concentration (MIC) values in response to multiple antifungal drugs. The patient died 10 days after diagnosis. To the best of our knowledge, this report is the second to demonstrate that P. janthinellum causes infection and is the first to present an infection (pneumonia) caused by P. janthinellumi in an SLE patient. Clinical and laboratory personnel should be aware that the Penicillium genus also contains pathogenic bacteria that cannot simply be treated as contaminants, especially in immunosuppressed patients.

Acknowledgments

The authors give special thanks to Professor Yunsong Yu (Zhejiang University) for his help with revising the manuscript. Xi Li and Laibin Zong are co-first authors for this study.

Abbreviations

SLE, systemic lupus erythematosus; BAL, bronchoalveolar; CT, computed tomography; PJP, Pneumocystis jiroveci pneumonia; GM, Aspergillus galactomannan; SDA, Sabouraud dextrose agar; MIC, minimum inhibitory concentration.

Ethics Approval and Consent for Publication

This study has been reviewed and approved by the Research Ethics Committee of the First Affiliated Hospital of Zhejiang University (ref#2019-1488). The husband of this patient provided consent for publication of the clinical details, and written informed consent was obtained.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors declare that they have no conflicts of interest.